Sentences with phrase «international currency exposure»

Most stock managers do not hedge all their international currency exposure, as research has shown currency hedging generally does not materially reduce volatility or increase returns over the long term for stocks.
Although international currency exposure provides some diversity to a portfolio you will ultimately be retiring in the dollars of your country.

Not exact matches

Important factors that could cause actual results to differ materially from those reflected in such forward - looking statements and that should be considered in evaluating our outlook include, but are not limited to, the following: 1) our ability to continue to grow our business and execute our growth strategy, including the timing, execution, and profitability of new and maturing programs; 2) our ability to perform our obligations under our new and maturing commercial, business aircraft, and military development programs, and the related recurring production; 3) our ability to accurately estimate and manage performance, cost, and revenue under our contracts, including our ability to achieve certain cost reductions with respect to the B787 program; 4) margin pressures and the potential for additional forward losses on new and maturing programs; 5) our ability to accommodate, and the cost of accommodating, announced increases in the build rates of certain aircraft; 6) the effect on aircraft demand and build rates of changing customer preferences for business aircraft, including the effect of global economic conditions on the business aircraft market and expanding conflicts or political unrest in the Middle East or Asia; 7) customer cancellations or deferrals as a result of global economic uncertainty or otherwise; 8) the effect of economic conditions in the industries and markets in which we operate in the U.S. and globally and any changes therein, including fluctuations in foreign currency exchange rates; 9) the success and timely execution of key milestones such as the receipt of necessary regulatory approvals, including our ability to obtain in a timely fashion any required regulatory or other third party approvals for the consummation of our announced acquisition of Asco, and customer adherence to their announced schedules; 10) our ability to successfully negotiate, or re-negotiate, future pricing under our supply agreements with Boeing and our other customers; 11) our ability to enter into profitable supply arrangements with additional customers; 12) the ability of all parties to satisfy their performance requirements under existing supply contracts with our two major customers, Boeing and Airbus, and other customers, and the risk of nonpayment by such customers; 13) any adverse impact on Boeing's and Airbus» production of aircraft resulting from cancellations, deferrals, or reduced orders by their customers or from labor disputes, domestic or international hostilities, or acts of terrorism; 14) any adverse impact on the demand for air travel or our operations from the outbreak of diseases or epidemic or pandemic outbreaks; 15) our ability to avoid or recover from cyber-based or other security attacks, information technology failures, or other disruptions; 16) returns on pension plan assets and the impact of future discount rate changes on pension obligations; 17) our ability to borrow additional funds or refinance debt, including our ability to obtain the debt to finance the purchase price for our announced acquisition of Asco on favorable terms or at all; 18) competition from commercial aerospace original equipment manufacturers and other aerostructures suppliers; 19) the effect of governmental laws, such as U.S. export control laws and U.S. and foreign anti-bribery laws such as the Foreign Corrupt Practices Act and the United Kingdom Bribery Act, and environmental laws and agency regulations, both in the U.S. and abroad; 20) the effect of changes in tax law, such as the effect of The Tax Cuts and Jobs Act (the «TCJA») that was enacted on December 22, 2017, and changes to the interpretations of or guidance related thereto, and the Company's ability to accurately calculate and estimate the effect of such changes; 21) any reduction in our credit ratings; 22) our dependence on our suppliers, as well as the cost and availability of raw materials and purchased components; 23) our ability to recruit and retain a critical mass of highly - skilled employees and our relationships with the unions representing many of our employees; 24) spending by the U.S. and other governments on defense; 25) the possibility that our cash flows and our credit facility may not be adequate for our additional capital needs or for payment of interest on, and principal of, our indebtedness; 26) our exposure under our revolving credit facility to higher interest payments should interest rates increase substantially; 27) the effectiveness of any interest rate hedging programs; 28) the effectiveness of our internal control over financial reporting; 29) the outcome or impact of ongoing or future litigation, claims, and regulatory actions; 30) exposure to potential product liability and warranty claims; 31) our ability to effectively assess, manage and integrate acquisitions that we pursue, including our ability to successfully integrate the Asco business and generate synergies and other cost savings; 32) our ability to consummate our announced acquisition of Asco in a timely matter while avoiding any unexpected costs, charges, expenses, adverse changes to business relationships and other business disruptions for ourselves and Asco as a result of the acquisition; 33) our ability to continue selling certain receivables through our supplier financing program; 34) the risks of doing business internationally, including fluctuations in foreign current exchange rates, impositions of tariffs or embargoes, compliance with foreign laws, and domestic and foreign government policies; and 35) our ability to complete the proposed accelerated stock repurchase plan, among other things.
Our clients» international stock exposure is held in local currencies rather than hedged to the U.S. dollar.
International equities and emerging markets have exposure to currency fluctuations, foreign taxes, political instability and the possibility for illiquid markets.
You should have the currency exposure in the international equity allocation you believe in, and not try to forecast currency trends.
Oakmark International Fund: The percentages of hedge exposure for each foreign currency are calculated by dividing the market value of all same - currency forward contracts by the market value of the underlying equity exposure to that currency.
International bonds give more diversification obviously but also a lot of exposure to currency risk.
The sorts of prudential controls which might be used are to limit the opportunities for residents to borrow in foreign currency (i.e. to prevent a repeat of the Bangkok International Banking Facility) and to monitor them when they do; and to keep very tight (indeed, unashamedly intrusive) constraints on banks» ability to have open foreign exchange positions or indirect exposure through foreign exchange loans.
In addition, if you're not getting enough foreign currency exposure (or you're getting too much) from your international stocks and bonds, you might think about investing in foreign currencies themselves.
State Street does offer separate exposure to corporates and government debt, but neither the SPDR Barclays International Treasury Bond ETF (BWX) nor the SPDR Barclays International Corporate Bond ETF (IBND) are currency hedged.
My model portfolios recommend US and international equity index funds that do not hedge their currency exposure.
Diversifying with international corporate bonds can potentially reduce exposure to market variations of a single currency, issuer, and asset class.
With the Canadian dollar on a bit of a run with this month's increase in Canadian interest rates, Parry wonders if Russo may want to consider hedging some of his exposure to international currencies.
Forex trading allows you to buy and sell currencies, similar to stock trading except you can do it 24 hours a day, five days a week, you have access to margin trading, and you gain exposure to international markets.
JPMorgan Government Bond Index - Emerging Markets Global Diversified Index (Unhedged) is a comprehensive global local emerging markets index, and consists of regularly traded, liquid fixed - rate, domestic currency government bonds to which international investors can gain exposure.
Because not all currencies inflate and deflate in lock step, international stock exposure can push the inflation beta for your stock portfolio in a positive direction.
Most portfolios should have between 25 % and 35 % exposure to U.S. and international stocks and those currencies.
There are international stock ETFs that hedge their currency exposure.
With respect to the International and Global Funds, investing in non-U.S. securities may entail risk due to non-US economic and political developments, exposure to non-US currencies, and different accounting and financial standards.
Investments in international and emerging markets securities and ADRs include exposure to risks including currency fluctuations, foreign taxes and regulations, and the potential for illiquid markets and political instability.
Thomas, I do believe if you buy IVV (S&P 500 denominated in USD traded on AMEX) you are right there are currency effects, and if you bought the XIN version on the TSX you have the product hedged — however for international exposure if you bought EFA on the AMEX you would not necessarily have those same CAD / USD currency effects.
The other International stock ETFs in the initial line - up are likely to be disappointing for investors wanting currency unhedged exposure to US and EAFE markets.
As gold is seen as safe heaven against fluctuating economy and equities market, every trader or investor wants to have exposure in this yellow metal but they do not want to trade in international market where investment required is huge and also base currency is USD.
This difference in currency exposure explains why XIN outperformed the TD International Index Fund by over 2.5 % during the last 12 months.
Seek personal advice about the opportunities and risks of adding some exposure to international bonds, property and shares, including the extra risks of fluctuations in currency exchange rates.
[1] To be fair, the decision to not hedge the currency exposure in international equities during the past decade had a lot to do with the weak U.S. dollar against major currencies.
For international bond exposure, however, most providers do hedge all or the majority of the currency exposure.
The company's international exposure makes the company vulnerable to foreign currency exchange risk as the the dollar fluctuates in value relative to the Euro, the Canadian dollar, the British Pound, etc..
Provides exposure to the growth potential of developed market companies while explicitly seeking to: Reduce volatility over a market cycle Diversify exposure across international countries Reduce concentration in dominant currencies
Risks and uncertainties include but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of pharmaceutical industry regulation and health care legislation in the United States and internationally; global trends toward health care cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; Merck's ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of Merck's patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and / or regulatory actions.
Risks and uncertainties include but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of pharmaceutical industry regulation and health care legislation in the United States and internationally; global trends toward health care cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; the company's ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the company's patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and / or regulatory actions.
Needing to buy forex at a future date is common in international business, creating what's called currency exposure and not managed carefully, it can erase profit on an international shipment of goods.
a b c d e f g h i j k l m n o p q r s t u v w x y z